Laekna Therapeutics Shanghai Co.
Latest round
- Series D
Last raised
- May 2022
Total raised
- $168M
Investors
- 8
About Laekna Therapeutics Shanghai Co.
, Ltd. is a biopharmaceutical company that focuses on the research and development of new drugs for cancer and liver fibrosis. The company's core team members all have over 20 years of new drug development capabilities in both the US and China, with experience from drug development to market. Founder and CEO Dr. Xiangyang Lv has worked for Pfizer and the US biotech start-up company Curis., Ltd., Ltd. was listed on Hong Kong Stock Exchange under the number 02105. The company is mainly engaged in the research and development of new antitumor drugs. It has established a new drug research and development platform for liver diseases and tumors. Its products include the AKT inhibitor afuresertib, CYP17A1 and CYP11B2 dual-target inhibitors, etc. The products can be used to treat breast cancer, ovarian cancer, prostate cancer, and other cancer diseases. The company generates revenue by providing new drugs for cancer and liver fibrosis.
Who invested in Laekna Therapeutics Shanghai Co.
8 investors across 4 rounds
See all investors in Laekna Therapeutics Shanghai Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Laekna Therapeutics Shanghai Co.
Who invested in Laekna Therapeutics Shanghai Co.?
Laekna Therapeutics Shanghai Co. has 8 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Laekna Therapeutics Shanghai Co. raised?
Laekna Therapeutics Shanghai Co. has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Laekna Therapeutics Shanghai Co. last raise money?
Laekna Therapeutics Shanghai Co.'s most recent round on record is a Series D, in May 2022.
What does Laekna Therapeutics Shanghai Co. do?
Laekna Therapeutics Shanghai Co. is a biotechnology company.
Where is Laekna Therapeutics Shanghai Co. headquartered?
Laekna Therapeutics Shanghai Co. is headquartered in Shanghai, China.
Which VCs invest in companies like Laekna Therapeutics Shanghai Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Laekna Therapeutics Shanghai Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Laekna Therapeutics Shanghai Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.